CRISCUOLO, ELENA
 Distribuzione geografica
Continente #
EU - Europa 330
NA - Nord America 289
AS - Asia 48
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 1
Totale 678
Nazione #
US - Stati Uniti d'America 289
SE - Svezia 188
IT - Italia 105
CN - Cina 35
FI - Finlandia 14
IE - Irlanda 9
RU - Federazione Russa 5
SG - Singapore 5
DE - Germania 4
IN - India 4
AU - Australia 3
CM - Camerun 3
A1 - Anonimo 2
HK - Hong Kong 2
PL - Polonia 2
BR - Brasile 1
EU - Europa 1
FR - Francia 1
GB - Regno Unito 1
KR - Corea 1
PH - Filippine 1
RO - Romania 1
ZA - Sudafrica 1
Totale 678
Città #
Ashburn 75
Milan 65
Princeton 39
Lawrence 38
Shanghai 27
New York 26
Helsinki 13
Dublin 9
Rome 7
Boardman 5
Ancona 4
Pune 4
South San Francisco 4
Turin 4
Washington 4
Bologna 3
Busto Arsizio 3
Council Bluffs 3
Los Angeles 3
Magnago 3
Melbourne 3
Bergamo 2
Como 2
Gatchina 2
Kunming 2
Kwai Chung 2
Las Vegas 2
Santa Clara 2
Seattle 2
Segrate 2
Bacoor 1
Bari 1
Beijing 1
Bloemfontein 1
Borås 1
Frankfurt am Main 1
Guangzhou 1
Houston 1
Lansing 1
Lappeenranta 1
London 1
Omsk 1
Redwood City 1
Rockville 1
San Diego 1
Shenzhen 1
St Petersburg 1
São Paulo 1
Vimodrone 1
Volgograd 1
Totale 380
Nome #
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 35
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 31
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 27
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 26
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 26
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 23
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 22
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 21
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 21
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 21
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 20
Evaluation of synergistic interactions of anti-HCV/E2 monoclonal antibodies 20
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 19
Bacteriophages and Their Immunological Applications against Infectious Threats 19
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 19
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 18
Viral Respiratory Pathogens and Lung Injury 18
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 18
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 18
The initial interplay between HIV and mucosal innate immunity 17
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 17
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 17
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 17
The interferon landscape along the respiratory tract impacts the severity of COVID-19 17
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 17
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 16
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 15
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 15
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 15
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 15
Phage Therapy: An Alternative to Antibiotics 14
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 14
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 14
Role and potential therapeutic use of antibodies against herpetic infections 13
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 13
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 13
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 12
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 12
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 12
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 12
Next Generation Vaccines for Infectious Diseases 12
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 11
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 10
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 10
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 10
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 8
Editorial: Viral escape of mucosal immunity in sexually transmitted diseases 5
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 5
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 4
null 1
Totale 805
Categoria #
all - tutte 9.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 5 0 0 0 0 0 6 0 0 0 0 1
2020/202113 2 0 0 2 4 0 2 0 0 3 0 0
2021/202284 6 3 10 10 13 7 9 2 2 9 0 13
2022/2023356 89 78 49 7 3 41 33 30 15 2 8 1
2023/2024297 1 20 42 62 19 62 9 25 13 8 18 18
Totale 805